GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heidelberg Pharma AG (XTER:HPHA) » Definitions » Pretax Margin %

Heidelberg Pharma AG (XTER:HPHA) Pretax Margin % : -350.83% (As of Feb. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Heidelberg Pharma AG Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Heidelberg Pharma AG's Pre-Tax Income for the three months ended in Feb. 2024 was €-4.45 Mil. Heidelberg Pharma AG's Revenue for the three months ended in Feb. 2024 was €1.27 Mil. Therefore, Heidelberg Pharma AG's pretax margin for the quarter that ended in Feb. 2024 was -350.83%.

The historical rank and industry rank for Heidelberg Pharma AG's Pretax Margin % or its related term are showing as below:

XTER:HPHA' s Pretax Margin % Range Over the Past 10 Years
Min: -1493.66   Med: -250.81   Max: -96.07
Current: -202.28


XTER:HPHA's Pretax Margin % is ranked worse than
53.54% of 1018 companies
in the Biotechnology industry
Industry Median: -154.275 vs XTER:HPHA: -202.28

Heidelberg Pharma AG Pretax Margin % Historical Data

The historical data trend for Heidelberg Pharma AG's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heidelberg Pharma AG Pretax Margin % Chart

Heidelberg Pharma AG Annual Data
Trend Nov14 Nov15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -138.77 -216.41 -1,493.66 -96.07 -206.37

Heidelberg Pharma AG Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -312.48 -400.95 9.50 -148.45 -350.83

Competitive Comparison of Heidelberg Pharma AG's Pretax Margin %

For the Biotechnology subindustry, Heidelberg Pharma AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heidelberg Pharma AG's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heidelberg Pharma AG's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Heidelberg Pharma AG's Pretax Margin % falls into.



Heidelberg Pharma AG Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Heidelberg Pharma AG's Pretax Margin for the fiscal year that ended in Nov. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Nov. 2023 )/Revenue (A: Nov. 2023 )
=-20.346/9.859
=-206.37 %

Heidelberg Pharma AG's Pretax Margin for the quarter that ended in Feb. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Feb. 2024 )/Revenue (Q: Feb. 2024 )
=-4.445/1.267
=-350.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Heidelberg Pharma AG  (XTER:HPHA) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Heidelberg Pharma AG Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Heidelberg Pharma AG's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Heidelberg Pharma AG (XTER:HPHA) Business Description

Traded in Other Exchanges
Address
Gregor-Mendel-Street 22, Ladenburg, DEU, 68526
Heidelberg Pharma AG is a biopharmaceutical company. It is focused on oncology and develops the toxin Amanitin into cancer therapies using its proprietary Antibody Targeted Amanitin Conjugate (ATAC) technology platform and advances the biological mode of action of the toxin as a novel therapeutic principle. The proprietary lead candidate is HDP-101 which is a BCMA (B-cell maturation antigen) - ATAC for multiple myeloma. In addition, the company offers preclinical contract research services. It operates through the following business divisions: Customer Specific Research, Diagnostics, and TherapeuticS.
Executives
Prof. Dr. Andreas Pahl Board of Directors

Heidelberg Pharma AG (XTER:HPHA) Headlines

No Headlines